$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
【用法用量】菲达替尼的推荐剂量是多少?注意事项有哪些
2025-10-19 11:44:20
Check Details
菲达替尼fedratinib怎么使用才是正确的?要注意什么
2025-10-19 11:44:20
Check Details
菲达替尼治疗骨髓纤维化疗效如何?有不良反应吗
2025-10-19 11:44:20
Check Details
全剂量Pacritinib治疗细胞减少型骨髓纤维化优于鲁索替尼
2025-10-19 11:44:20
Check Details
新基高度选择性JAK2抑制剂菲达替尼
2025-10-19 11:44:20
Check Details
美国FDA批准骨髓纤维化新药Fedratinib(Inrebic)上市
2025-10-19 11:44:20
Check Details
新药菲达替尼Fedratinib上市!他是否值得信赖
2025-10-19 11:44:20
Check Details
最新数据速递| Momelotinib治疗骨髓纤维化具有输血独立反应
2025-10-19 11:44:20
Check Details
一起了解菲达替尼(菲卓替尼)的治疗效果及副作用
2025-10-19 11:44:20
Check Details
菲达替尼(fedratinib)在天津能买到吗?多少钱一盒
2025-10-19 11:44:20
Check Details
与单纯羟基脲相比,鲁索替尼可改善骨髓纤维化患者的总生存期
2025-10-19 11:44:20
Check Details
骨髓纤维化靶向治疗药:菲达替尼
2025-10-19 11:44:20
Check Details
1
2
...
122
123
124
125
126
127
128
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
2
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
3
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
4
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
5
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
6
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
7
A Key Therapeutic Breakthrough Against T315I-Mutant CML
8
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
9
Tafasitamab and Lenalidomide Combination Therapy Guide
10
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
11
Gilteritinib Professional Medication Guide & Dosage Management
12
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies